List of Tables
Table 1. Global Anti-depressant Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-depressant Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-depressant Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-depressant Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-depressant Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-depressant Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-depressant Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-depressant Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-depressant Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-depressant Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-depressant Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Anti-depressant Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-depressant Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-depressant Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-depressant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-depressant Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-depressant Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Anti-depressant Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-depressant Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Anti-depressant Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-depressant Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-depressant Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-depressant Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-depressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-depressant Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-depressant Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-depressant Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-depressant Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-depressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-depressant Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-depressant Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-depressant Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-depressant Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-depressant Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-depressant Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-depressant Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-depressant Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-depressant Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-depressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-depressant Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-depressant Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-depressant Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-depressant Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-depressant Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-depressant Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-depressant Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-depressant Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-depressant Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-depressant Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-depressant Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-depressant Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Anti-depressant Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Anti-depressant Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-depressant Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-depressant Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-depressant Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-depressant Drugs Price (USD/Unit) by Type (2019-2024)
Table 59. Global Anti-depressant Drugs Price (USD/Unit) by Type (2025-2030)
Table 60. Global Anti-depressant Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-depressant Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-depressant Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Anti-depressant Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Anti-depressant Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-depressant Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-depressant Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-depressant Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-depressant Drugs Price (USD/Unit) by Application (2019-2024)
Table 69. Global Anti-depressant Drugs Price (USD/Unit) by Application (2025-2030)
Table 70. Alkermes Corporation Information
Table 71. Alkermes Description and Business Overview
Table 72. Alkermes Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Alkermes Anti-depressant Drugs Product
Table 74. Alkermes Recent Developments/Updates
Table 75. Allergan Corporation Information
Table 76. Allergan Description and Business Overview
Table 77. Allergan Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Allergan Anti-depressant Drugs Product
Table 79. Allergan Recent Developments/Updates
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Bristol-Myers Squibb Anti-depressant Drugs Product
Table 84. Bristol-Myers Squibb Recent Developments/Updates
Table 85. Eli Lilly and Company Corporation Information
Table 86. Eli Lilly and Company Description and Business Overview
Table 87. Eli Lilly and Company Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Eli Lilly and Company Anti-depressant Drugs Product
Table 89. Eli Lilly and Company Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. GlaxoSmithKline Anti-depressant Drugs Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. Lundbeck Corporation Information
Table 96. Lundbeck Description and Business Overview
Table 97. Lundbeck Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Lundbeck Anti-depressant Drugs Product
Table 99. Lundbeck Recent Developments/Updates
Table 100. Merck Corporation Information
Table 101. Merck Description and Business Overview
Table 102. Merck Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Merck Anti-depressant Drugs Product
Table 104. Merck Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Pfizer Anti-depressant Drugs Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Teva Pharmaceutical Industries Corporation Information
Table 111. Teva Pharmaceutical Industries Description and Business Overview
Table 112. Teva Pharmaceutical Industries Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Teva Pharmaceutical Industries Anti-depressant Drugs Product
Table 114. Teva Pharmaceutical Industries Recent Developments/Updates
Table 115. Takeda Pharmaceutical Company Corporation Information
Table 116. Takeda Pharmaceutical Company Description and Business Overview
Table 117. Takeda Pharmaceutical Company Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Takeda Pharmaceutical Company Anti-depressant Drugs Product
Table 119. Takeda Pharmaceutical Company Recent Developments/Updates
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Description and Business Overview
Table 122. AstraZeneca Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. AstraZeneca Anti-depressant Drugs Product
Table 124. AstraZeneca Recent Developments/Updates
Table 125. Johnson and Johnson Corporation Information
Table 126. Johnson and Johnson Description and Business Overview
Table 127. Johnson and Johnson Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Johnson and Johnson Anti-depressant Drugs Product
Table 129. Johnson and Johnson Recent Developments/Updates
Table 130. Sanofi Corporation Information
Table 131. Sanofi Description and Business Overview
Table 132. Sanofi Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Sanofi Anti-depressant Drugs Product
Table 134. Sanofi Recent Developments/Updates
Table 135. Sun Pharmaceuticals Corporation Information
Table 136. Sun Pharmaceuticals Description and Business Overview
Table 137. Sun Pharmaceuticals Anti-depressant Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Sun Pharmaceuticals Anti-depressant Drugs Product
Table 139. Sun Pharmaceuticals Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Anti-depressant Drugs Distributors List
Table 143. Anti-depressant Drugs Customers List
Table 144. Anti-depressant Drugs Market Trends
Table 145. Anti-depressant Drugs Market Drivers
Table 146. Anti-depressant Drugs Market Challenges
Table 147. Anti-depressant Drugs Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-depressant Drugs
Figure 2. Global Anti-depressant Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-depressant Drugs Market Share by Type in 2023 & 2030
Figure 4. Selective Serotonin Reuptake Inhibitor (SSRI) Product Picture
Figure 5. Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) Product Picture
Figure 6. Tricyclic Antidepressant (TCA) Product Picture
Figure 7. Monoamine Oxidase Inhibitor (MAOI) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Anti-depressant Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Anti-depressant Drugs Market Share by Application in 2023 & 2030
Figure 11. Major Depressive Disorder
Figure 12. Obsessive-Compulsive Disorder
Figure 13. Generalized Anxiety Disorder
Figure 14. Panic Disorder
Figure 15. Others
Figure 16. Global Anti-depressant Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Anti-depressant Drugs Market Size (2019-2030) & (US$ Million)
Figure 18. Global Anti-depressant Drugs Sales (2019-2030) & (K Units)
Figure 19. Global Anti-depressant Drugs Average Price (USD/Unit) & (2019-2030)
Figure 20. Anti-depressant Drugs Report Years Considered
Figure 21. Anti-depressant Drugs Sales Share by Manufacturers in 2023
Figure 22. Global Anti-depressant Drugs Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Anti-depressant Drugs Players: Market Share by Revenue in 2023
Figure 24. Anti-depressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Anti-depressant Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Anti-depressant Drugs Sales Market Share by Country (2019-2030)
Figure 27. North America Anti-depressant Drugs Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Anti-depressant Drugs Sales Market Share by Country (2019-2030)
Figure 31. Europe Anti-depressant Drugs Revenue Market Share by Country (2019-2030)
Figure 32. Germany Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Anti-depressant Drugs Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Anti-depressant Drugs Revenue Market Share by Region (2019-2030)
Figure 39. China Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Anti-depressant Drugs Sales Market Share by Country (2019-2030)
Figure 50. Latin America Anti-depressant Drugs Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Anti-depressant Drugs Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Anti-depressant Drugs Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. U.A.E Anti-depressant Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Anti-depressant Drugs by Type (2019-2030)
Figure 60. Global Revenue Market Share of Anti-depressant Drugs by Type (2019-2030)
Figure 61. Global Anti-depressant Drugs Price (USD/Unit) by Type (2019-2030)
Figure 62. Global Sales Market Share of Anti-depressant Drugs by Application (2019-2030)
Figure 63. Global Revenue Market Share of Anti-depressant Drugs by Application (2019-2030)
Figure 64. Global Anti-depressant Drugs Price (USD/Unit) by Application (2019-2030)
Figure 65. Anti-depressant Drugs Value Chain
Figure 66. Anti-depressant Drugs Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed